NO922945L - Pyrazolderivater - Google Patents

Pyrazolderivater

Info

Publication number
NO922945L
NO922945L NO92922945A NO922945A NO922945L NO 922945 L NO922945 L NO 922945L NO 92922945 A NO92922945 A NO 92922945A NO 922945 A NO922945 A NO 922945A NO 922945 L NO922945 L NO 922945L
Authority
NO
Norway
Prior art keywords
hydrogen
treatment
pyrazole
consciousness
bromine
Prior art date
Application number
NO92922945A
Other languages
English (en)
Other versions
NO922945D0 (no
Inventor
Ralf Plate
Duncan Robertson Rae
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of NO922945D0 publication Critical patent/NO922945D0/no
Publication of NO922945L publication Critical patent/NO922945L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Pyrazolderivat med formelen I .N. d) hvor R., er X^V og R? er hydrogen, eller R. N l CH3 hvor n er l eller 2 og R, er hydrogen eller halogen; og R^ er brom eller jod; eller et farmasøytisk tilfredsstillende salt derav. Forbindelsene har muskarin-egenskaper og kan anvendes for behandling av bevissthetsforstyrrelser, som smertestillende midler og for behandling av kolinergiske mangler.
NO92922945A 1991-07-26 1992-07-24 Pyrazolderivater NO922945L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91306870 1991-07-26

Publications (2)

Publication Number Publication Date
NO922945D0 NO922945D0 (no) 1992-07-24
NO922945L true NO922945L (no) 1993-01-27

Family

ID=8208356

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922945A NO922945L (no) 1991-07-26 1992-07-24 Pyrazolderivater

Country Status (11)

Country Link
US (1) US5227394A (no)
EP (1) EP0525879A1 (no)
JP (1) JPH05213934A (no)
KR (1) KR930002322A (no)
AU (1) AU647357B2 (no)
CA (1) CA2074601A1 (no)
FI (1) FI923325A (no)
IE (1) IE922270A1 (no)
MX (1) MX9204370A (no)
NO (1) NO922945L (no)
ZA (1) ZA925523B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11514654A (ja) * 1995-11-06 1999-12-14 ハー・ルンドベック・アクチェゼルスカベット 外傷による脳損傷の治療方法
US5733912A (en) * 1997-02-19 1998-03-31 Abbott Laboratories 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
AU7639598A (en) 1997-05-29 1998-12-30 H. Lundbeck A/S Treatment of schizophrenia and psychosis
NZ532283A (en) * 2001-10-17 2005-06-24 Ucb S Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
GB0127731D0 (en) * 2001-11-20 2002-01-09 Coin Controls Coin handling apparatus
FR2862647B1 (fr) * 2003-11-25 2008-07-04 Aventis Pharma Sa Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
PL2023909T3 (pl) * 2006-05-04 2010-04-30 Solvay Pharm Bv Agonisty muskarynowe do leczenia zaburzeń kontroli impulsów
BR112013009823A2 (pt) 2010-10-22 2016-07-05 Bayer Ip Gmbh novos compostos heterocíclicos como pesticidas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
DE3877470T2 (de) * 1987-09-10 1993-06-24 Merck Sharp & Dohme Oxazole und thiazole zur behandlung seniler demenz.
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
EP0402056A3 (en) * 1989-06-06 1991-09-04 Beecham Group p.l.c. Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
ATE136031T1 (de) * 1989-10-07 1996-04-15 Beecham Group Plc Azabizyklische verbindungen, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen

Also Published As

Publication number Publication date
JPH05213934A (ja) 1993-08-24
FI923325A0 (fi) 1992-07-21
CA2074601A1 (en) 1993-01-27
ZA925523B (en) 1993-04-28
AU2041792A (en) 1993-01-28
KR930002322A (ko) 1993-02-22
AU647357B2 (en) 1994-03-17
US5227394A (en) 1993-07-13
NO922945D0 (no) 1992-07-24
MX9204370A (es) 1993-03-01
IE922270A1 (en) 1993-01-27
EP0525879A1 (en) 1993-02-03
FI923325A (fi) 1993-01-27

Similar Documents

Publication Publication Date Title
NO163819C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo(4,5-c)kinolin og derivater derav.
ES8604559A1 (es) Un metodo para preparar derivados de piperazina
HU9301155D0 (en) Methods for producing steroide derivatives and for their application in medical treatment
AU2001272666A1 (en) 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
ATE102930T1 (de) Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend.
MY131641A (en) Indoline derivatives, process of preparation and use
DK519985D0 (da) Quinoloncarboxylsyrederivater, fremgangsmaade til fremstilling deraf og antibakterielt middel indeholdende saadanne derivater
NO922945L (no) Pyrazolderivater
DK0526313T3 (da) Nye ureaderivater, deres fremstilling og terapeutiske anvendelse
TW324009B (en) Pyrazole condensation ring derivative, its production process and its use as androgen inhibitor
NO913331L (no) 4-substituerte dihydropyrido(4,3-d)pyrimidiner for behandling av hudforstyrrelser.
NO922521L (no) Piperidinyletanolderivater med terapeutisk virkning
ES2043515A1 (es) Procedimiento para la preparacion de nuevos derivados de 1-difenilmetilpiperazina.
NO985063L (no) Pyridyl- og pyrimidyl-piperaziner i behandling av substansmisbruks forstyrr
ES8400384A1 (es) Procedimiento para la preparacion de derivados de carbaciclina.
DE59202744D1 (de) 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung.
ATE160567T1 (de) Psoralen-derivate, deren herstellung und verwendung als arzneimittel
GR3006108T3 (no)
ES465136A1 (es) Procedimiento para la preparacion de nuevos derivados de he-lebrigenina
DK0434833T3 (da) 9-fluor-prostaglandinderivater, fremgangsmåde til fremstilling deraf samt farmaceutiske anvendelse
NO164170C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzhydryl-4-cinnamyl-piperazinderivater.
ES465366A2 (es) Un procedimiento de preparacion de derivados de metoxi-2- benzamidas.
MY104630A (en) 4(1h) ouinoline derivatives